Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

SPL Medical

SPL Medical?uq=8lCq2teR
2015 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
2 INVESTORS
Description

Developer of a cancer metastasis diagnostic technology created to improve MRI imaging. The company offers a proprietary diagnostic approach, including contrast agent, Combidex, which consists of nano-sized iron oxide particles and is intended for diagnostics of lymph node metastases in patients with malignant tumors to save the lives of hundreds of cancer patients annually, enabling patients to get a friendly diagnosis of cancer metastasis.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Transistorweg 5
  • 6534 AT Nijmegen
  • Netherlands

+31 024 000 0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore SPL Medical’s full profile, request a free trial.

SPL Medical Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 01-May-2017 Completed Startup
1. Corporate 01-Jun-2016 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

SPL Medical Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Oost NL Venture Capital Minority 000 0000 000000 0
B.E. Imaging Corporation Minority 000 0000 000000 0

SPL Medical Executive Team (2)

Name Title Board
Seat
Contact
Info
J├╝rgen Feuerstein Ph.D Chief Executive Officer & Managing Director
Harrie Baars MD Chief Business Officer